ALEAF (Aleafia Health) YoY EBITDA Growth: 91.53% (As of Mar. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ALEAF Aleafia Health Inc ALEAF
12 GF Score
Price $0.00
View Full Analysis

What is Aleafia Health YoY EBITDA Growth?

Aleafia Health ALEAF -99.00% 12 YoY EBITDA Growth is 91.53% as of Mar. 2023. GuruFocus rates ALEAF with a GF Score™ of 12/100.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Aleafia Health's YoY EBITDA Growth for the quarter that ended in Mar. 2023 was 91.53%.

Aleafia Health's EBITDA per Share for the three months ended in Mar. 2023 was $-0.02.

Aleafia Health YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Aleafia Health's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aleafia Health YoY EBITDA Growth Chart

Aleafia Health Annual Data
Trend Jan12 Jan13 Jan14 Jan15 Jan16 Oct17 Dec18 Dec19 Dec20 Mar23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,166.67 10.94 43.86 -889.06 94.47

Aleafia Health Quarterly Data
Oct17 Jan18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Jun22 Sep22 Dec22 Mar23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -320.00 100.18 223.53 -587.50 91.53
ALEAF
12GF Score
Aleafia Health Inc ALEAF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aleafia Health YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Aleafia Health's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (A: Mar. 2023 )
=(EBITDA per Share (A: Mar. 2023 )-EBITDA per Share (A: Dec. 2020 ))/ | EBITDA per Share (A: Dec. 2020 ) |
=(-0.035--0.633)/ | -0.633 |
=94.47 %

Aleafia Health's YoY EBITDA Growth for the quarter that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (Q: Mar. 2023 )
=(EBITDA per Share (Q: Mar. 2023 )-EBITDA per Share (Q: Sep. 2021 )) / | EBITDA per Share (Q: Sep. 2021 )) |
=(-0.016--0.189)/ | -0.189 |
=91.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 91.53% mean?
Aleafia Health (ALEAF) has a YoY EBITDA Growth of 91.53% as of Mar. 2023. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Aleafia Health and its competitors.
Is Aleafia Health's YoY EBITDA Growth too high?
Aleafia Health's current YoY EBITDA Growth is 91.53%. Overall, Aleafia Health has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Aleafia Health's YoY EBITDA Growth compare to ZTS and CTLT?
Aleafia Health's YoY EBITDA Growth of 91.53% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Aleafia Health and its competitors. Aleafia Health's current YoY EBITDA Growth is 91.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aleafia Health stock overvalued right now?
Aleafia Health (ALEAF) has a current YoY EBITDA Growth of 91.53%. The current YoY EBITDA Growth is 91.53%. Aleafia Health's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Aleafia Health (ALEAF), the current YoY EBITDA Growth is 91.53% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aleafia Health Business Description

Address 85 Basaltic Road, Concord, ON, CAN, L4K 1G4
Aleafia Health Inc is a vertically integrated cannabis health and wellness company which owns three cannabis product and cultivation facilities where it produces a diverse portfolio of commercially high-margin derivative products including oils, capsules and sprays.
12GF Score

Get the complete analysis for ALEAF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price